Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08
Published August 29, 2018 · Recall initiated: August 14, 2018
Summary
FDA records drug Class III recall D-1112-2018, published August 29, 2018 and initiated August 14, 2018. Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Status: Terminated; Reported quantity: 408 cartons; Lot: Batch 3096049. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Distributor
- Nationwide USA
- Lot
- Batch 3096049
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cardsMay 18, 2022
- FDAEsomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cardsMay 18, 2022
- FDAValsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets perAugust 29, 2018
- FDACamber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for: CamberAugust 29, 2018
- FDALoxapine Capsules, USP 50 mg, packaged in 100 Unit Dose capsules, Rx only, Manufactured by MylanMay 30, 2018
- FDALoxapine Capsules, USP 25 mg, packaged in 100 Unit Dose Capsules, Rx only, Manufactured by MylanMay 30, 2018
Questions about this recall
Was Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08 recalled?
Yes. FDA published recall D-1112-2018 on August 29, 2018. Reported hazard: Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer
What should I do if I have this product?
Voluntary: Firm initiated · Letter